Skip to main content

Table 1 Different concentrations of ATRA and R428 used

From: AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

Inhibitor

Concentrations used (μM)

ATRA

0.41

0.82

1.62

R428

0.62

1.25

2.50

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us